Search hospitals
>
Michigan
>
Flint
Hurley Medical Center
Claim this profile
Flint, Michigan 48503
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Brain Tumor
Conducts research for Ovarian Cancer
657 reported clinical trials
7 medical researchers
Summary
Hurley Medical Center is a medical facility located in Flint, Michigan. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Brain Tumor, Ovarian Cancer and other specialties. Hurley Medical Center is involved with conducting 657 clinical trials across 690 conditions. There are 7 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.
Area of expertise
Breast Cancer
Hurley Medical Center has run 92 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Hurley Medical Center has run 91 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Tareq Al Baghdadi
Genesys Hurley Cancer Institute
9 years of reported clinical research
Christopher M. Reynolds, MD
Saint Joseph Mercy Hospital
3 years of reported clinical research
Philip J. Stella
Saint Joseph Mercy Hospital
5 years of reported clinical research
Elie G. Dib
Genesys Hurley Cancer Institute
7 years of reported clinical research
Clinical Trials running at Hurley Medical Center
Lung Cancer
Breast Cancer
Ovarian Cancer
Bladder Cancer
Breast cancer
Esophageal cancer
Cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Multiple Myeloma
Ceralasertib + Durvalumab
for Non-Small Cell Lung Cancer
This phase III trial compares the effect of adding AZD6738 to durvalumab versus durvalumab alone to increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery. AZD6738 may stop the growth of tumor cells and may kill them by blocking some of the enzymes needed for cell growth. Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Adding AZD6738 to durvalumab may increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery.
Recruiting
2 awards
Phase 3
10 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting
2 awards
Phase 3
31 criteria
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting
2 awards
Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Hurley Medical Center?
Hurley Medical Center is a medical facility located in Flint, Michigan. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Brain Tumor, Ovarian Cancer and other specialties. Hurley Medical Center is involved with conducting 657 clinical trials across 690 conditions. There are 7 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.
Where is Hurley Medical Center located?
**Hurley Medical Center Directions:** - **Address:** 1 Hurley Plaza, Flint, MI. - **Driving:** Take I-475 N to exit 4 for Saginaw St, then head west on Saginaw St. - **Alternative:** For real-time traffic updates, consider using Waze.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Hurley Medical Center, call the Financial Assistance office at (810) 262-9255. For inquiries about your stay, contact the Patient Relations office at (810) 262-9220.
What insurance does Hurley Medical Center accept?
Hurley Medical Center accepts most U.S. insurances. They advise verifying coverage for Bariatric Surgery or Morbid Obesity with your insurance carrier. They offer Advanced Neuropsychology and Pediatric Psychology Services as an approved provider for many health insurance plans and provide a discount program for uninsured individuals requiring financial support.
What awards or recognition has Hurley Medical Center received?
Hurley Medical Center, located in Flint, Michigan, is renowned for its exceptional patient care and holds accreditation from The Joint Commission. The hospital boasts a range of distinguished programs including a Level I Trauma Center, Level III Neonatal Intensive Care Unit, and a Nationally-accredited Breast Cancer Program, among others. It is also committed to community health through initiatives targeting childhood obesity, diabetes education, asthma management, and improving food access.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.